» Articles » PMID: 34725715

β-Adrenoceptor Activation Stimulates IL-6 Production Via PKA, ERK1/2, Src, and Beta-Arrestin2 Signaling Pathways in Human Bronchial Epithelia

Overview
Journal Lung
Specialty Pulmonary Medicine
Date 2021 Nov 2
PMID 34725715
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: β-Adrenoceptor agonists are widely used to treat asthma because of their bronchial-dilation effects. We previously reported that isoprenaline, via the apical and basolateral β-adrenoceptor, induced Cl secretion by activating cyclic AMP (cAMP)-dependent pathways in human bronchial epithelia. Despite these results, whether and how the β-adrenoceptor-mediated cAMP-dependent pathway contributes to pro-inflammatory cytokine release in human bronchial epithelia remains poorly understood.

Methods: We investigated β-adrenoceptor-mediated signaling pathways involved in the production of two pro-inflammatory cytokines, interleukin (IL)-6 and IL-8, in 16HBE14o- human bronchial epithelia. The effects of isoprenaline or formoterol were assessed in the presence of protein kinase A (PKA), exchange protein directly activated by cAMP (EPAC), Src, and extracellular signal-regulated protein kinase (ERK)1/2 inhibitors. The involvement of β-arrestin2 was examined using siRNA knockdown.

Results: Isoprenaline and formoterol (both β agonists) induced IL-6, but not IL-8, release, which could be inhibited by ICI 118,551 (β antagonist). The PKA-specific inhibitor, H89, partially inhibited IL-6 release. Another intracellular cAMP receptor, EPAC, was not involved in IL-6 release. Isoprenaline-mediated IL-6 secretion was attenuated by dasatinib, a Src inhibitor, and PD98059, an ERK1/2 inhibitor. Isoprenaline treatment also led to ERK1/2 phosphorylation. In addition, knockdown of β-arrestin2 by siRNA specifically suppressed cytokine release when a high concentration of isoprenaline (1 mM) was used.

Conclusion: Our results suggest that activation of the β-adrenoceptor in 16HBE14o- cells stimulated the PKA/Src/ERK1/2 and/or β-arrestin2 signaling pathways, leading to IL-6 release. Therefore, our data reveal that β-adrenoceptor signaling plays a role in the immune regulation of human airway epithelia.

Citing Articles

A guided journey through the pathophysiology of pulmonary hypertension-from measured metabolites to the mechanism of action of drugs.

Weinstein N, Carlsen J, Schulz S, Stapleton T, Henriksen H, Travnik E Front Cardiovasc Med. 2024; 11:1341145.

PMID: 38845688 PMC: 11153715. DOI: 10.3389/fcvm.2024.1341145.


LUNG Year in Review: 2021.

Dicpinigaitis P Lung. 2022; 200(1):1-4.

PMID: 35041063 PMC: 8764491. DOI: 10.1007/s00408-022-00510-9.

References
1.
Rubini A . Interleukin-6 and Lung Inflammation: Evidences of A Causing Role in Inducing Respiratory System Resistance Increments. Inflamm Allergy Drug Targets. 2013; . View

2.
Nguyen L, Al-Sawalha N, Parra S, Pokkunuri I, Omoluabi O, Okulate A . β-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility. Proc Natl Acad Sci U S A. 2017; 114(43):E9163-E9171. PMC: 5664525. DOI: 10.1073/pnas.1710196114. View

3.
Zhang R, Yip C, Pan K, Cai M, Ko W . β adrenoceptor signaling regulates ion transport in 16HBE14o- human airway epithelial cells. J Cell Physiol. 2020; 235(11):8387-8401. DOI: 10.1002/jcp.29683. View

4.
Roscioni S, Kistemaker L, Menzen M, Elzinga C, Gosens R, Halayko A . PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells. Respir Res. 2009; 10:88. PMC: 2764632. DOI: 10.1186/1465-9921-10-88. View

5.
Vaughan D, Millman E, Godines V, Friedman J, Tran T, Dai W . Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation. J Biol Chem. 2006; 281(11):7684-92. DOI: 10.1074/jbc.M500328200. View